Hypercoagulable State Induced Spinal Cord Stroke After Coronavirus Disease 19 Infection

Lisda Amalia1

  • 1Department of Neurology, Faculty Medicine, Universitas Padjadjaran/RSUP Dr. Hasan Sadikin Bandung, Bandung, Indonesia.

Journal of Blood Medicine
|December 22, 2021
PubMed

Insights

Spinal cord stroke is a rare complication of coronavirus disease 2019 (COVID-19). This case report highlights COVID-19-induced coagulopathy leading to spinal artery occlusion and stroke, with partial recovery after anticoagulant therapy.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Vascular Medicine

Background:

  • Spinal cord stroke is an uncommon but serious complication following coronavirus disease 2019 (COVID-19) infection.
  • COVID-19 is associated with a hypercoagulable state, increasing the risk of thromboembolic events, including spinal artery occlusion.

Observation:

  • A 60-year-old male with confirmed COVID-19 presented with acute flaccid paraplegia, sensory loss, and autonomic dysfunction 14 days post-infection.
  • Clinical presentation included elevated D-dimer and fibrinogen levels, consistent with a hypercoagulable state.
  • Magnetic resonance imaging revealed spinal artery stenosis at the T12 level, indicative of ischemia.

Findings:

  • The patient experienced spinal cord ischemia attributed to COVID-19-related coagulopathy and spinal artery occlusion.
  • Treatment with subcutaneous anticoagulation led to partial recovery of motor function, sensory symptoms, and autonomic function.

Implications:

  • Coronavirus disease 2019 can precipitate endothelial damage and activate thrombotic pathways, potentially causing spinal cord stroke.
  • This case underscores the importance of considering thromboembolic complications in patients with neurological deficits following COVID-19.
  • Early diagnosis and anticoagulant therapy may improve outcomes in COVID-19-associated spinal cord ischemia.
Abstract